title: Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers.
abstract: OBJECTIVE
  Patients who receive tumour necrosis factor-alpha (TNF-alpha) blockers are mostly immunosuppressed. A study was performed to investigate whether an interferon-gamma (IFN-gamma) assay could represent an alternative approach to the tuberculin skin test (TST) for the diagnosis of latent tuberculosis infection (LTBI) in these patients.
  
  
  METHODS
  We prospectively enrolled 106 individuals into the study in two groups. Group 1 consisted of 38 healthy individuals and Group 2 included 68 patients with chronic inflammatory diseases evaluated for LTBI before the use of TNF-alpha blockers.
  
  
  RESULTS
  Of all participants, nine had indeterminate IFN-gamma test results. Agreement between the two tests was poor in both groups (kappa values respectively -0.54 and 0.18). In a total of 97 subjects, 10 (10.3%) were positive by the IFN-gamma test and 49 (50.5%) by TST.
  
  
  CONCLUSIONS
  We found poor agreement between TST and the IFN-gamma test in our study. Our limited preliminary data should be accepted as a basis for designing future studies that will be helpful for physicians to decide whether the IFN-gamma test is more sensitive than the TST test in detecting LTBI before the use of TNF-alpha blockers.
authors.affiliation: Hacettepe University Faculty of Medicine, Pediatric Pulmonary Diseases Unit, Ankara, Turkey. nazanc@hacettepe.edu.tr
authors.forename: N
authors.initials: N
authors.lastname: Cobanoglu
authors.forename: U
authors.initials: U
authors.lastname: Ozcelik
authors.forename: U
authors.initials: U
authors.lastname: Kalyoncu
authors.forename: S
authors.initials: S
authors.lastname: Ozen
authors.forename: S
authors.initials: S
authors.lastname: Kiraz
authors.forename: N
authors.initials: N
authors.lastname: Gurcan
authors.forename: M
authors.initials: M
authors.lastname: Kaplan
authors.forename: D
authors.initials: D
authors.lastname: Dogru
authors.forename: E
authors.initials: E
authors.lastname: Yalcin
authors.forename: S
authors.initials: S
authors.lastname: Pekcan
authors.forename: M
authors.initials: M
authors.lastname: Kose
authors.forename: R
authors.initials: R
authors.lastname: Topaloglu
authors.forename: N
authors.initials: N
authors.lastname: Besbas
authors.forename: A
authors.initials: A
authors.lastname: Bakkaloglu
authors.forename: N
authors.initials: N
authors.lastname: Kiper
mesh_terms: D000328:Adult; D001500:BCG Vaccine; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007371:Interferon-gamma / Q000378:metabolism*; D008297:Male; D014374:Tuberculin Test; D014376:Tuberculosis / Q000175:diagnosis* / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D001500:BCG Vaccine; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma